The SIDER database of drugs and side effects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER ('Side Effect Resource', http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug-ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug-ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“One of the most widely utilized ADE databases derived from drug label data is SIDER, constructed using a dictionary-based named entity recognition (NER) method to extract adverse event terms from FDA Structured Product Labeling (SPLs) drug labels13.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Self-citationDrug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“For example, it was shown that ADRs can be used to predict drug targets (1) and that causal relations between targets and ADRs can be elucidated (2,3).”
BackgroundSelf-citationThe Stanford typed dependencies representation
de Marneffe, M.-C., & Manning, C. D. (2008) · Coling 2008: Proceedings of the workshop on Cross-Framework and Cross-Domain Parser Evaluation - CrossParser '08 · doi:10.3115/1608858.1608859 · Cited by 918
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Self-citationPREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
STITCH 4: integration of protein–chemical interactions with user data
Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487
Self-citationExtraction of potential adverse drug events from medical case reports
Gurulingappa, H., Mateen‐Rajpu, A., & Toldo, L. (2012) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-3-15 · Cited by 211
The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text
Pafilis, E., Frankild, S. P., Fanini, L., Faulwetter, S., Pavloudi, C., Vasileiadou, A., Arvanitidis, C., & Jensen, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065390 · Cited by 206
Self-citationCai, M., Xu, Q., Pan, Y.-J., Pan, W., Ji, N., Li, Y.-B., Jin, H.-J., Liu, K., & Ji, Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1066 · Cited by 131
Systematic identification of proteins that elicit drug side effects
Kuhn, M., Al Banchaabouchi, M., Campillos, M., Jensen, L. J., Gross, C., Gavin, A., & Bork, P. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.10 · Cited by 120
Self-citation
Cited by
Items 201–300 of 1,001
Artificial Intelligence and Data Mining for the Pharmacovigilance of Drug–Drug Interactions
Hauben, M. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.01.002 · Cited by 65
Ahmed, F., Lee, J. W., Samantasinghar, A., Kim, Y. S., Kim, K. H., Kang, I. S., Memon, F. H., Lim, J. H., & Choi, K. H. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.902123 · Cited by 65
Drug–drug similarity measure and its applications
Huang, L., Luo, H., Li, S., Wu, F., & Wang, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa265 · Cited by 65
A novel graph attention model for predicting frequencies of drug–side effects from multi-view data
Zhao, H., Zheng, K., Li, Y., & Wang, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab239 · Cited by 65
Predicting Polypharmacy Side-effects Using Knowledge Graph Embeddings.
Nováček, V., & Mohamed, S. K. (2020) · PubMed Central · Cited by 65
Drug Repurposing: Claiming the Full Benefit from Drug Development
Kort, E. J., & Jovinge, S. V. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01484-5 · Cited by 63
Chemical representation learning for toxicity prediction
Born, J., Markert, G., Janakarajan, N., Kimber, T. B., Volkamer, A., Martínez, M. R., & Manica, M. (2023) · Digital Discovery · doi:10.1039/d2dd00099g · Cited by 63
The OREGANO knowledge graph for computational drug repurposing
Boudin, M., Diallo, G., Drancé, M., & Mougin, F. (2023) · Scientific Data · doi:10.1038/s41597-023-02757-0 · Cited by 62
Recent Advances in the Machine Learning-Based Drug-Target Interaction Prediction
Zhang, W., Lin, W., Zhang, D., Wang, S., Shi, J., & Niu, Y. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180821094047 · Cited by 62
Exploring Causal Learning Through Graph Neural Networks: An In‐Depth Review
Job, S., Tao, X., Cai, T., Xie, H., Li, L., Li, Q., & Yong, J. (2025) · Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery · doi:10.1002/widm.70024 · Cited by 62
Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
Liu, A., Walter, M., Wright, P. S. R., Bartosik, A., Dolciami, D., Elbasir, A., Yang, H., & Bender, A. (2021) · Biology Direct · doi:10.1186/s13062-020-00285-0 · Cited by 61
Predicting and Understanding the Human Microbiome’s Impact on Pharmacology
Hitchings, R., & Kelly, L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.04.014 · Cited by 61
Zolnoori, M., Fung, K. W., Patrick, T. B., Fontelo, P. A., Kharrazi, H. H. K., Faiola, A. J., Wu, Y. S. S., Eldredge, C. E., Luo, J., Conway, M., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.12.005 · Cited by 61
Drug-target interaction/affinity prediction: Deep learning models and advances review
Vefghi, A., Rahmati, Z., & Akbari, M. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110438 · Cited by 60
Insights from pharmacokinetic models of host-microbiome drug metabolism
Zimmermann‐Kogadeeva, M., Zimmermann, M., & Goodman, A. L. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1667724 · Cited by 60
Deep Transferable Compound Representation across Domains and Tasks for Low Data Drug Discovery
Abbasi, K., Poso, A., Ghasemi, J. B., Amanlou, M., & Masoudi‐Nejad, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00626 · Cited by 60
Context-enriched molecule representations improve few-shot drug discoveryPreprint
Schimunek, J., Seidl, P., Friedrich, L., Kühn, D., Rippmann, F., Hochreiter, S., & Klambauer, G. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2305.09481 · Cited by 60
DPSP: a multimodal deep learning framework for polypharmacy side effects prediction
Masumshah, R., & Eslahchi, C. (2023) · Bioinformatics Advances · doi:10.1093/bioadv/vbad110 · Cited by 60
Li, B., Lin, M., Chen, T., & Wang, L. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad398 · Cited by 59
Bai, J., Kong, S., & Gomes, C. P. (2020) · International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2020/595 · Cited by 59
Seal, S., Spjuth, O., Hosseini-Gerami, L., García-Ortegón, M., Singh, S., Bender, A., & Carpenter, A. E. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01834 · Cited by 58
Yong, U., Kim, D., Kim, H., Hwang, D. G., Cho, S., Nam, H., Kim, S., Kim, T. Y., Jeong, U., Kim, K., et al. (2023) · Advanced Materials · doi:10.1002/adma.202208983 · Cited by 58
Ly, T., Pamer, C. A., Dang, O., Brajovic, S., Haider, S., Botsis, T., Milward, D., Winter, A. G., Lu, S. F., & Ball, R. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.05.019 · Cited by 58
A critical assessment of Traditional Chinese Medicine databases as a source for drug discovery
Wang, Y., Liu, M., Jafari, M., & Tang, J. P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1303693 · Cited by 58
SEGA: Structural Entropy Guided Anchor View for Graph Contrastive LearningPreprint
Wu, J., Chen, X., Shi, B., Li, S., & Xu, K. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2305.04501 · Cited by 58
ASGARD is a single-cell guided pipeline to aid repurposing of drugs
He, B., Xiao, Y., Liang, H., Huang, Q., Du, Y., Li, Y., Garmire, D., Sun, D., & Garmire, L. X. (2023) · Nature Communications · doi:10.1038/s41467-023-36637-3 · Cited by 57
Drug repurposing by integrated literature mining and drug–gene–disease triangulation
Sun, P., Guo, J., Winnenburg, R., & Baumbach, J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.008 · Cited by 57
Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation
Tan, Y., Hu, Y. Q., Liu, X., Yin, Z., Chen, X.-W., & Liu, M. (2016) · Methods · doi:10.1016/j.ymeth.2016.07.023 · Cited by 56
Kotsampasakou, E., & Ecker, G. F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00518 · Cited by 56
An Analytical Review of Computational Drug Repurposing
Sadeghi, S. S., & Keyvanpour, M. R. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2933825 · Cited by 56
Jung, W. J., Goo, S., Hwang, T., Lee, H., Kim, Y., Chae, J., Yun, H., & Jung, S. (2024) · Pharmaceuticals · doi:10.3390/ph17030382 · Cited by 56
Jain, S., Kotsampasakou, E., & Ecker, G. F. (2018) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-018-0116-z · Cited by 56
The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
Guthrie, L., Wolfson, S., & Kelly, L. (2019) · eLife · doi:10.7554/elife.42866 · Cited by 55
A survey on adverse drug reaction studies: data, tasks and machine learning methods
Nguyễn, Đ. A., Nguyen, C. H., & Mamitsuka, H. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz140 · Cited by 55
Machine learning prediction of side effects for drugs in clinical trials
Galeano, D., & Paccanaro, A. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100358 · Cited by 55
Estimation of the prevalence of adverse drug reactions from social media
Nguyen, T., Larsen, M. E., O’Dea, B., Phung, D., Venkatesh, S., & Christensen, H. M. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.03.013 · Cited by 55
Neural Message Passing for Multi-label Classification
Lanchantin, J., Sekhon, A., & Qi, Y. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-46147-8_9 · Cited by 55
A data-driven approach for predicting the impact of drugs on the human microbiome
Algavi, Y. M., & Borenstein, E. (2023) · Nature Communications · doi:10.1038/s41467-023-39264-0 · Cited by 54
Using chemical and biological data to predict drug toxicity
Liu, A., Seal, S., Yang, H., & Bender, A. (2023) · SLAS Discovery · doi:10.1016/j.slasd.2022.12.003 · Cited by 54
The 2019 n2c2/UMass Lowell shared task on clinical concept normalization
Luo, Y.-F., Henry, S., Wang, Y., Shen, F., Uzuner, O., & Rumshisky, A. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa106 · Cited by 54
Iqbal, E., Mallah, R., Rhodes, D. R., Wu, H., Romero, A., Chang, N., Dzahini, O., Pandey, C., Broadbent, M. T. M., Stewart, R. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187121 · Cited by 54
Jarada, T. N., Rokne, J. G., & Alhajj, R. (2020) · Knowledge-Based Systems · doi:10.1016/j.knosys.2020.106585 · Cited by 54
In Silico Prediction and Insights Into the Structural Basis of Drug Induced Nephrotoxicity
Shi, Y., Hua, Y., Wang, B., Zhang, R., & Li, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.793332 · Cited by 54
Verma, N., Kumar, A., Kaushik, V., Brünnert, D., Chahar, K. R., Pandey, J., & Goyal, P. (2016) · Scientific Reports · doi:10.1038/srep33949 · Cited by 54
Mol2Context-vec: learning molecular representation from context awareness for drug discovery
Lv, Q., Chen, G., Zhao, L., Zhong, W., & Chen, C. Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab317 · Cited by 54
The evolving role of disproportionality analysis in pharmacovigilance
Fusaroli, M., Raschi, E., Poluzzi, E., & Hauben, M. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2368817 · Cited by 54
A similarity-based deep learning approach for determining the frequencies of drug side effects
Zhao, H., Wang, S., Zheng, K., Zhao, Q., Zhu, F., & Wang, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab449 · Cited by 54
Review of Predicting Synergistic Drug Combinations
Pan, Y., Ren, H., Lan, L., Li, Y., & Huang, T. (2023) · Life · doi:10.3390/life13091878 · Cited by 54
Large-Scale Prediction of Drug-Target Interaction: a Data-Centric Review
Cheng, T., Hao, M., Takeda, T., Bryant, S. H., & Wang, Y. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0092-6 · Cited by 53
Vilar, S., & Hripcsak, G. M. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw048 · Cited by 53
Old drugs, new uses: Drug repurposing in hematological malignancies
Kale, V. P., Habib, H., Chitren, R. J., Patel, M., Pramanik, K. C., Jonnalagadda, S. C., Challagundla, K. B., & Pandey, M. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.005 · Cited by 53
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
Hwang, W., Lei, W., Katritsis, N. M., MacMahon, M., Chapman, K. L., & Han, N. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.004 · Cited by 52
Innovative in Silico Approaches for Characterization of Genes and Proteins
Bhat, G. R., Sethi, I., Rah, B., Kumar, R., & Afroze, D. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.865182 · Cited by 52
Survey of Similarity-Based Prediction of Drug-Protein Interactions
Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 52
Roman, M., Roman, D. L., Ostafe, V., Ciorsac, A. A., & Isvoran, A. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2353-1 · Cited by 52
Application of machine learning in drug side effect prediction: databases, methods, and challenges
Zhao, H., Zhong, J., Liang, X., Xie, C., & Wang, S. (2024) · Frontiers of Computer Science · doi:10.1007/s11704-024-31063-0 · Cited by 52
Biomedical discovery through the integrative biomedical knowledge hub (iBKH)
Su, C., Hou, Y., Zhou, M., Rajendran, S., Maasch, J. R. M. A., Abedi, Z., Zhang, H., Bai, Z., Cuturrufo, A., Guo, W. L., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106460 · Cited by 51
The Alzheimer’s Knowledge Base: A Knowledge Graph for Alzheimer Disease Research
Romano, J. D., Truong, V. Q., Kumar, R., Venkatesan, M., Graham, B. E., Hao, Y., Matsumoto, N., Li, X., Wang, Z. P., Ritchie, M. D., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/46777 · Cited by 51
Recent Studies of Artificial Intelligence on In Silico Drug Distribution Prediction
Tran, T. T. V., Tayara, H., & Chong, K. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031815 · Cited by 50
Biomedical data, computational methods and tools for evaluating disease–disease associations
Xiang, J., Zhang, J., Zhao, Y., Wu, F.-X., & Li, M. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac006 · Cited by 49
The promise of explainable deep learning for omics data analysis: Adding new discovery tools to AI
Santorsola, M., & Lescai, F. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.06.002 · Cited by 49
Ye, L., Ngan, D. K., Xu, T., Liu, Z., Zhao, J., Sakamuru, S., Zhang, L., Zhao, T., Xia, M., Simeonov, A. M., et al. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116250 · Cited by 49
Drug knowledge bases and their applications in biomedical informatics research
Zhu, Y., Elemento, O., Pathak, J., & Wang, F. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx169 · Cited by 49
Paci, P., Fiscon, G., Conte, F., Wang, R., Handy, D. E., Farina, L., & Loscalzo, J. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00221-0 · Cited by 49
Structural and Functional View of Polypharmacology
Moya‐García, A. A., Adeyelu, T. T., Krüger, F. A., Dawson, N. L., Lees, J., Overington, J. P., Orengo, C. A., & Ranea, J. A. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10012-x · Cited by 49
Development of a human genetics-guided priority score for 19,365 genes and 399 drug indications
Duffy, Á., Petrazzini, B. O., Stein, D. F., Park, J. K., Forrest, I. S., Gibson, K., Vy, H. M. T., Chen, R. K., Márquez‐Luna, C., Mort, M. E., et al. (2024) · Nature Genetics · doi:10.1038/s41588-023-01609-2 · Cited by 48
A comprehensive review of computational techniques for the prediction of drug side effects
Sachdev, K., & Gupta, M. K. (2020) · Drug Development Research · doi:10.1002/ddr.21669 · Cited by 48
Hosseini, S., & Zhou, X. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac588 · Cited by 48
Molecular geometric deep learning
Shen, C., Luo, J., & Xia, K. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100621 · Cited by 48
Heterogeneous graph inference with matrix completion for computational drug repositioning
Yang, M., Huang, L., Xu, Y., Lu, C., & Wang, J. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa1024 · Cited by 48
Descriptive prediction of drug side‐effects using a hybrid deep learning model
Lee, C. Y., & Chen, Y. P. (2021) · International Journal of Intelligent Systems · doi:10.1002/int.22389 · Cited by 48
Monnin, P., Legrand, J., Husson, G., Ringot, P., Tchechmedjiev, A., Jonquet, C., Napoli, A., & Coulet, A. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2693-9 · Cited by 48
Molecular Joint Representation Learning via Multi-Modal Information of SMILES and Graphs
Wu, T., Tang, Y. S., Sun, Q., & Xiong, L. (2023) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2023.3253862 · Cited by 47
Crofton, K. M., Bassan, A., Behl, M., Chushak, Y. G., Fritsche, E., Gearhart, J. M., Marty, M. S., Mumtaz, M. M., Pavan, M., Ruíz, P., et al. (2022) · Computational Toxicology · doi:10.1016/j.comtox.2022.100223 · Cited by 47
A comprehensive comparison of molecular feature representations for use in predictive modeling
Stepišnik, T., Škrlj, B., Wicker, J. S., & Kocev, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104197 · Cited by 47
Zhu, J., Liu, Y., Zhang, Y., & Li, D. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3048059 · Cited by 47
Computational models for the prediction of adverse cardiovascular drug reactions
Jamal, S., Ali, W., Nagpal, P., Grover, S., & Grover, A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1918-z · Cited by 47
Structural Analysis and Prediction of Hematotoxicity Using Deep Learning Approaches
Long, T.-Z., Shi, S., Liu, S., Lü, A., Liu, Z., Li, M., Hou, T., & Cao, D. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01088 · Cited by 46
Medical Concept Normalization for Online User-Generated Texts
Lee, K., Hasan, S. A., Farri, O., Choudhary, A., & Agrawal, A. (2017) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi.2017.59 · Cited by 45
DSGAT: predicting frequencies of drug side effects by graph attention networks
Xu, X., Yue, L., Li, B., Liu, Y., Wang, Y., Zhang, W., & Wang, L. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab586 · Cited by 45
Serafini, M. M., Sepehri, S., Midali, M., Stinckens, M., Biesiekierska, M., Wolniakowska, A., Gatzios, A., Rundén‐Pran, E., Reszka, E., Marinovich, M., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03703-8 · Cited by 44
Biomolecule and Bioentity Interaction Databases in Systems Biology: A Comprehensive Review
Baltoumas, F. A., Zafeiropoulou, S., Karatzas, E., Koutrouli, M., Thanati, F., Voutsadaki, K., Gkonta, M., Hotova, J., Kasionis, I., Hatzis, P., et al. (2021) · Biomolecules · doi:10.3390/biom11081245 · Cited by 44
Hua, Y., Shi, Y., Cui, X., & Li, X. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10255-x · Cited by 44
Sutherland, J. J., Yonchev, D., Fekete, A., & Urbán, L. (2023) · Nature Communications · doi:10.1038/s41467-023-40064-9 · Cited by 44
Machine Learning Techniques for Predicting Drug-Related Side Effects: A Scoping Review
Toni, E., Ayatollahi, H., Abbaszadeh, R., & Siahpirani, A. F. (2024) · Pharmaceuticals · doi:10.3390/ph17060795 · Cited by 44
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
Li, Y., Yepes, A. J., & Xiao, C. (2020) · Drug Safety · doi:10.1007/s40264-020-00943-2 · Cited by 44
Jung, Y.-S., Kim, Y., & Cho, Y. (2021) · Methods · doi:10.1016/j.ymeth.2021.10.007 · Cited by 44
Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials
Federer, C., Yoo, M., & Tan, A. C. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.742 · Cited by 44
Che, M., Yao, K., Che, C., Cao, Z., & Kong, F. (2021) · Future Internet · doi:10.3390/fi13010013 · Cited by 43
A Novel Approach for Drug-Target Interactions Prediction Based on Multimodal Deep Autoencoder
Wang, H., Wang, J., Dong, C., Lian, Y., Liu, D., & Yan, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01592 · Cited by 43
In silico methods for the prediction of drug toxicity
Rajpoot, K., Desai, N., Koppisetti, H., Tekade, M., Sharma, M. C., Behera, S. K., & Tekade, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98367-9.00012-3 · Cited by 43
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
Wen, Z., Yu, L., Hao, Y., Delavan, B., Huang, R., Mikailov, M., Tong, W., Li, M., & Liu, Z. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.06.006 · Cited by 43
Gheorghita, F.-I., Bocanet, V.-I., & Iantovics, L. B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1632775 · Cited by 43
Advances in machine intelligence‐driven virtual screening approaches for big‐data
Kumar, N., & Acharya, V. (2023) · Medicinal Research Reviews · doi:10.1002/med.21995 · Cited by 42
Modular Multi–Source Prediction of Drug Side–Effects With DruGNN
Bongini, P., Scarselli, F., Bianchini, M., Dimitri, G. M., Pancino, N., & Lió, P. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3175362 · Cited by 42
In silico prediction of potential drug‐induced nephrotoxicity with machine learning methods
Gong, Y., Teng, D., Wang, Y., Gu, Y., Wu, Z., Li, W., Tang, Y., & Liu, G. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4331 · Cited by 42
Network approaches for modeling the effect of drugs and diseases
Rintala, T., Ghosh, A., & Fortino, V. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac229 · Cited by 42
Semi-supervised Hierarchical Drug Embedding in Hyperbolic Space
Yu, K., Visweswaran, S., & Batmanghelich, K. N. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00681 · Cited by 42
Leveraging genetic interactions for adverse drug-drug interaction prediction
Qian, S., Liang, S., & Yu, H. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007068 · Cited by 42
Inverse similarity and reliable negative samples for drug side-effect prediction
Zheng, Y., Peng, H., Ghosh, S., Lan, C., & Li, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-018-2563-x · Cited by 42
Metadata
- Authors
- Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P.
- Affiliations
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Copenhagen (DK)
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-19
- Volume
- 44
- Issue
- D1
- Pages
- D1075-D1079
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702794
- OpenAlex
- W2145578524
- Cited by
- 1,451
- References
- 18
- Citations by year
- 2026: 123 · 2025: 199 · 2024: 194 · 2023: 160 · 2022: 156 · 2021: 183 · 2020: 131 · 2019: 111 · 2018: 82 · 2017: 74 · 2016: 37
- FWCI
- 51.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- European Molecular Biology Laboratory
- Novo Nordisk (NNF14CC0001)
- Novo Nordisk Fonden (NNF 14CC0001)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- SIDER, adverse drug reactions, drug safety, drug indications, package inserts, natural language processing, therapeutic target
- MeSH terms
- Drug Labeling, Internet, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.